In this study, we investigated the effect of adding two different intermetallics, Ti5Si3 and TiSi2, for the preparation of TiB2-SiC-B4C composites. As part of the research, stoichiometric composites consisting only of two phases TiB2 and SiC were obtained. The TiB2-SiC-B4C composites were prepared via pressureless sintering. The presence of the phases in the sintered composites was confirmed using X-ray diffraction and scanning electron microscopy. The SEM-EDS examination revealed that the TiB2 and SiC phases were formed during the composite process synthesis and were distributed homogeneously in the B4C matrix. The obtained results allowed us to usually exceed 2000 °C and the use of specialized equipment for firing, that is, vacuum or protective atmosphere furnaces as well as control and measurement equipment. Such an approach generates high costs that are decisive for the economics of the technological processes. In the case of our compositions, it is possible to lower the temperature to 1650 °C. The TiB2-SiC-B4C composites were classified as UHTCs.
The aim of this study was to analyse the thermal properties of glazes from the SiO2-Al2O3-CaO-MgO-Na2O system during the addition of zirconium oxide. The paper describes the effect of the addition of zirconium oxide on characteristic temperatures obtained with a high-temperature microscope and a mechanical dilatometer. Based on these data, the course of the logarithm curves of the viscosity of the glazes was determined on the basis of the Vogel–Tamman–Fulcher model. The analysis of thermal effects during the heating and cooling of glazes was also carried out on the basis of measurements made by means of differential scanning calorimetry and analysis of the phase composition at selected temperatures. The obtained results constitute a comprehensive characteristic of the thermal properties of glazes, in which the amount of zirconium oxide increases—from 0 to 24 mass%.
Boron Neutron Capture Therapy (BNCT) is a therapeutic approach used to treat malignancies that are difficult to localise and typically inoperable. This therapy involves two stages: the administration of the boron (10B) isotope, which selectively enters cancer cells without affecting healthy tissue, followed by irradiation of the tumour with a neutron beam. In this study, boron carbide (B4C), a ceramic material with exceptional physical and chemical properties, was used as a nanoparticle platform for BNCT. The surface of the boron carbide nanoparticles was optimised by modifying them with compounds such as dextrin, dextran T70, sorbitol, lysine, and arginine. Boron carbide was synthesised directly from boron and carbon and then subjected to grinding, washing, and centrifugation. The unmodified and modified samples were analysed for their particle size, zeta potential, and toxicity against glioblastoma T98G cells. Additionally, FTIR spectroscopy confirmed the successful surface modifications. The results demonstrate that boron carbide, as a ceramic material, can be effectively functionalised with biocompatible compounds. Among the tested modifications, B4C-dextrin and B4C-dextran T70 exhibited the highest toxicity towards cancer cells, demonstrating the potential of ceramic platforms in biomedical applications.